Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| OKYO Pharma Ltd | 9,177,903 | reported | 27 Oct 2023 | tx 6+8,057,039 |
| Accustem Sciences Inc. | 6,502,400 | reported | 13 Jun 2025 | tx 17+403,074 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 13 Jun 2025 | PURCHASE | Accustem Sciences Inc. | 2,000 | 1.00 USD | |
| 13 Jun 2025 | PURCHASE | Accustem Sciences Inc. | 400 | 1.10 USD | |
| 11 Jun 2025 | PURCHASE | Accustem Sciences Inc. | 28,205 | 0.39 USD | |
| 12 Jun 2025 | PURCHASE | Accustem Sciences Inc. | 8,991 | 0.83 USD | |
| 08 Apr 2025 | PURCHASE | Accustem Sciences Inc. | 35,000 | 0.67 USD | |
| 09 Apr 2025 | PURCHASE | Accustem Sciences Inc. | 3,000 | 0.67 USD | |
| 07 Apr 2025 | PURCHASE | Accustem Sciences Inc. | 35,000 | 0.65 USD | |
| 18 Mar 2025 | PURCHASE | Accustem Sciences Inc. | 100,000 | 0.45 USD | |
| 07 Apr 2025 | PURCHASE | Accustem Sciences Inc. | 17,802 | 0.61 USD | |
| 31 Dec 2024 | PURCHASE | Accustem Sciences Inc. | 100,000 | 0.38 USD | first after silence |
| 27 Oct 2023 | OTHER | OKYO Pharma Ltd | 70,071 | 1.50 USD | |
| 23 Oct 2023 | OTHER | OKYO Pharma Ltd | 499,468 | 1.50 USD | |
| 30 Dec 2022 | PURCHASE | Accustem Sciences Inc. | 5,000 | 1.40 USD | |
| 02 Dec 2022 | PURCHASE | Accustem Sciences Inc. | 3,729 | 1.42 USD | |
| 18 Nov 2022 | PURCHASE | Accustem Sciences Inc. | 24,500 | 1.05 USD | |
| 01 Aug 2022 | PURCHASE | Accustem Sciences Inc. | 10,000 | 0.79 USD | |
| 08 Jun 2022 | PURCHASE | Accustem Sciences Inc. | 20,000 | 0.50 USD | |
| 19 May 2022 | PURCHASE | OKYO Pharma Ltd | 5,800,000 | 0.08 USD | |
| 19 May 2022 | PURCHASE | OKYO Pharma Ltd | 37,500 | 4.00 USD | |
| 17 May 2022 | PURCHASE | OKYO Pharma Ltd | 1,625,000 | 0.06 USD | |
| 26 Apr 2022 | PURCHASE | Accustem Sciences Inc. | 5,266 | 1.49 USD | |
| 25 Apr 2022 | PURCHASE | Accustem Sciences Inc. | 4,181 | 1.35 USD |
1 purchase reported after at least 12 months of silence — most recent on 31 Dec 2024.